Ambulatory Blood Pressure Monitoring (ABPM) Devices Market Expected to Reach $309.3 Million by 2031—Allied Market Research

According to a new report published by Allied Market Research, titled, “Ambulatory Blood Pressure Monitoring (ABPM) Devices Market," The ambulatory blood pressure monitoring devices Market size was valued at $160.80 million in 2021, and is estimated to reach $309.3 million by 2031, growing at a CAGR of 6.7% from 2022 to 2031.

ABPM devices measure ambulatory blood pressure and are designed to avoid the effects of white coat hypertension, while providing accurate sleep blood pressure readings. Ambulatory blood pressure monitoring is a diagnostic test which is used to determine the presence of hypertension by measuring blood pressure during daily activities for 24 hours. This device is a portable blood pressure machine worn as a belt, in which cuff is attached around the upper arm of the body. It can be used to confirm a detection of high blood pressure, which is called as white-coat hypertension

The global ABPM devices market size is driven by rise in number of hypertension cases due to obesity, cardiovascular diseases, and diabetes. Moreover, growth in geriatric population, high demand for non-invasive devices for measuring blood pressure, and transformation from physician-centered to the patient-centered model fuel the growth of the market. For instance, in August 2022, CariAI Inc. introduced new 24-hour ambulatory blood pressure monitoring system namely BPAro. It is a compact portable blood pressure monitoring device which automatically records patient blood pressure. In addition, in January 2021, Aktila SA launched a 24/7 automated blood pressure monitoring system in the U.S. Moreover, in June 2019, A&D Medical, which is a global leader in blood pressure monitoring solutions, launched new line of professional blood pressure monitors which helps clinicians to diagnose hypertension and manage blood pressure level. This new line of products includes ambulatory blood pressure monitors and professional office blood pressure monitors. This next generation ambulatory blood pressure is used in diagnosis and assessment of hypertension. Both of these models, namely TM-2440 and TM-2441 are lightweight and help improve patient compliance. The TM-2441 model has high tech sensor which records environmental parameters along with blood pressure measurements for 24 hours. Thus, increase in in number of product launches by key players drives the ambulatory blood pressure monitoring devices market growth.

Furthermore, as per Organization for Economic Co-operation and Development, in 2018, a total of 45,307 cases of coronary artery bypass grafting procedures were performed in Germany. Hence, the surge in incidences of emergency surgeries and extensive use of ambulatory blood pressure monitoring devices post-surgery to detect blood pressure level propel the growth of the market. Moreover, development of pharmaceutical & medical device industries and improvement in healthcare spending are anticipated to drive the growth of the ambulatory blood pressure monitoring devices market.

For instance, in January 2020, Omron Corporation launched HeartGuide device. This device is a wearable product that monitors blood pressure. It also helps to understand the fluctuation of blood pressure in day time and helps to get control over high blood pressure. Regular self-monitoring of blood pressure can significantly reduce the risk of cardiac disorders. Moreover, high demand from the U.S. and pre-order availability for HeartGuide led Omron to file more than 80 patents to develop HeartGuide in the design of wrist watch that ensures the accuracy and reliability. Thus, presence of innovative product lines fuels the growth of the ambulatory blood pressure monitoring (ABPM) devices market.

However, expensive ABPM monitors and lack of awareness in emerging regions are expected to restrain the market growth. Conversely, huge market potential in the emerging markets, such as China and India, and increase in healthcare expenditure in developing countries are expected to provide lucrative opportunities to the market players.

The ABPM devices market is segmented into product, end user and region. By product, it is bifurcated into arm blood pressure monitoring devices and wrist blood pressure monitoring devices. The arm ABPM device segment acquired the largest share in 2021, and is expected to remain dominant throughout the forecast period attributed to the surge in usage of ambulatory blood pressure monitors.

By end user, it is divided into hospitals, ambulatory surgical centers (ASCs), and others. The hospitals segment acquired the largest share in 2021, and is expected to remain dominant throughout the forecast period attributed to increase in number of hospital admissions.

By region, the market is studied across North America, Europe, Asia-Pacific, and LAMEA. North America accounted for the largest ambulatory blood pressure monitoring devices market share in 2021, and is expected to remain dominant throughout the forecast period, owing to increase in large number of key players in the region which provide wide range of ambulatory blood pressure monitoring devices.

The key players that operate in the ABPM devices industry include Baxter International Inc., Bosch+Sohn GmbH Co KG, BPL Ltd, Contec Medical Systems Co., Ltd, GE Healthcare, Halma Plc, Omron Corporation, OSI Systems Inc. (Spacelabs Healthcare Inc.), Schiller AG, and Vaso Corporation.

KEY BENEFITS FOR STAKEHOLDERS

• The study provides an in-depth analysis of the market size, and the current ambulatory blood pressure monitoring devices market trends & future estimations to elucidate imminent investment pockets.
• It presents a quantitative analysis of the market from 2021 to 2031 to enable stakeholders to capitalize on the prevailing market opportunities.
• Extensive analysis of the market based on procedures and services assists to understand the trends in the industry.
• Key players and their strategies are thoroughly analyzed to understand the competitive outlook of the market.